Patient Guide: Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT02354014
Status: 🟢 Enrolling Now
Condition: Multidrug-Resistant Tuberculosis
Phase: PHASE2

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Maputo,
  • • Dasmarinas,
  • • Quezon City,
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB - Join Clinical Trial NCTNCT02354014

How to Join This Clinical Trial - NCTNCT02354014

Learn how to participate in this PHASE2 trial studying an investigational therapy for Multidrug-Resistant Tuberculosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multidrug-Resistant Tuberculosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multidrug-Resistant Tuberculosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT02354014 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Maputo, 00000 - Mozambique

Status: RECRUITING

Clinical Research Site

Dasmarinas, 4114 - Philippines

Status: RECRUITING

Clinical Research Site

Quezon City, 1100 - Philippines

Status: COMPLETED

Clinical Research Site

San Vincent Silang, 000 - Philippines

Status: RECRUITING

Clinical Research Site

Moscow, 119991 - Russian Federation

Status: COMPLETED

Clinical Research Site

Durban, 4001 - South Africa

Status: COMPLETED

Clinical Research Site

Johannesburg, 2131 - South Africa

Status: RECRUITING

Clinical Research Site

Port Elizabeth, 6200 - South Africa

Status: RECRUITING

Clinical Research Site

Stellenboch, 7600 - South Africa

Status: RECRUITING

Clinical Research Site

Kampala, - Uganda

Status: TERMINATED

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Multidrug-Resistant Tuberculosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships